12/19
09:58 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $639.00 to $723.00. They now have an "overweight" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $639.00 to $723.00. They now have an "overweight" rating on the stock.
12/9
09:22 am
argx
Should You Increase Your Holdings in argenx SE (ARGX)? [Yahoo! Finance]
Low
Report
Should You Increase Your Holdings in argenx SE (ARGX)? [Yahoo! Finance]
12/3
10:14 am
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $655.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $655.00 price target on the stock.
12/2
03:10 pm
argx
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
Low
Report
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
11/26
01:00 am
argx
argenx to Present at Upcoming Investor Conferences
Low
Report
argenx to Present at Upcoming Investor Conferences
11/21
10:20 am
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $675.00 price target on the stock, up previously from $646.00.
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $675.00 price target on the stock, up previously from $646.00.
11/21
09:00 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Evercore ISI from $675.00 to $706.00. They now have an "outperform" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Evercore ISI from $675.00 to $706.00. They now have an "outperform" rating on the stock.
11/20
01:16 pm
argx
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $617.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $617.00 price target on the stock.
11/20
01:00 am
argx
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Medium
Report
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
11/18
09:23 am
argx
Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now? [Yahoo! Finance]
11/12
08:03 am
argx
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $697.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $697.00 price target on the stock.
11/11
07:30 am
argx
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
Low
Report
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
11/5
07:27 am
argx
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $715.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $715.00 price target on the stock.
11/5
07:27 am
argx
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $715.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $715.00 price target on the stock.
11/5
01:00 am
argx
argenx to Participate at Upcoming Investor Conferences
Low
Report
argenx to Participate at Upcoming Investor Conferences
11/4
09:31 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $640.00 to $670.00. They now have an "overweight" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $640.00 to $670.00. They now have an "overweight" rating on the stock.
11/2
06:52 am
argx
argenx SE (NASDAQ: ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
argenx SE (NASDAQ: ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
11/1
03:39 pm
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Guggenheim from $585.00 to $665.00. They now have a "buy" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Guggenheim from $585.00 to $665.00. They now have a "buy" rating on the stock.
11/1
02:51 pm
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $547.00 to $639.00. They now have an "overweight" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $547.00 to $639.00. They now have an "overweight" rating on the stock.
11/1
10:34 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Piper Sandler from $553.00 to $620.00. They now have an "overweight" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Piper Sandler from $553.00 to $620.00. They now have an "overweight" rating on the stock.
11/1
09:40 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $560.00 to $646.00. They now have an "outperform" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $560.00 to $646.00. They now have an "outperform" rating on the stock.
11/1
08:32 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at JMP Securities from $497.00 to $606.00. They now have a "market outperform" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at JMP Securities from $497.00 to $606.00. They now have a "market outperform" rating on the stock.
11/1
08:15 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at HC Wainwright from $533.00 to $617.00. They now have a "buy" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at HC Wainwright from $533.00 to $617.00. They now have a "buy" rating on the stock.
11/1
07:32 am
argx
argenx SE (NASDAQ: ARGX) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $650.00 price target on the stock, up previously from $515.00.
Low
Report
argenx SE (NASDAQ: ARGX) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $650.00 price target on the stock, up previously from $515.00.
11/1
07:32 am
argx
argenx SE (NASDAQ: ARGX) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Low
Report
argenx SE (NASDAQ: ARGX) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.